Contact this trialFirst, we need to learn more about you.
Hormone Therapy
SX-682 + Enzalutamide for Prostate Cancer
Recruiting1 awardPhase 2
San Francisco, California
This trial is studying a combination of SX-682 and enzalutamide in men with advanced prostate cancer that has spread and is no longer responding to standard treatment. The aim is to see if
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service